0001551986-23-000026.txt : 20230421
0001551986-23-000026.hdr.sgml : 20230421
20230421170833
ACCESSION NUMBER: 0001551986-23-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230421
FILED AS OF DATE: 20230421
DATE AS OF CHANGE: 20230421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sensenig Bethany
CENTRAL INDEX KEY: 0001899935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37797
FILM NUMBER: 23837186
MAIL ADDRESS:
STREET 1: C/O 9 METERS BIOPHARMA, INC.
STREET 2: 8480 HONEYCUTT ROAD, SUITE 120
CITY: RALEIGH
STATE: NC
ZIP: 27615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 9 METERS BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001551986
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273948465
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4509 CREEDMOOR ROAD
STREET 2: SUITE 201
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919-275-1933
MAIL ADDRESS:
STREET 1: 4509 CREEDMOOR ROAD
STREET 2: SUITE 201
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Monster Digital, Inc.
DATE OF NAME CHANGE: 20150930
FORMER COMPANY:
FORMER CONFORMED NAME: Tandon Digital, Inc.
DATE OF NAME CHANGE: 20120611
4
1
wf-form4_168211130140021.xml
FORM 4
X0407
4
2023-04-21
0
0001551986
9 METERS BIOPHARMA, INC.
NMTR
0001899935
Sensenig Bethany
C/O 9 METERS BIOPHARMA, INC.
4509 CREEDMOOR RD, STE 600
RALEIGH
NC
27612
0
1
0
0
Chief Financial Officer
0
Common stock
2023-04-21
4
S
0
9100
1.21
D
41077
D
Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 15, 2023.
The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.23. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
/s/ Lorna A. Knick, as power of attorney
2023-04-21